Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Procedure for the Discrimination of Tissue Resistivity in Breast Cancer Patients

NCT03402997 is registered in ClinicalTrials.gov with Ente Ospedaliero Cantonale, Bellinzona as lead sponsor.

NCT NCT03402997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Procedure for the Discrimination of Tissue Resistivity in Breast Cancer Patients
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Phase
Observational
Overall status
Completed
Start date
December 15, 2017
Completion date
September 25, 2019
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer